Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marina B Klein

Showing results (1-10 of 250) with videos related to

Pageof 25
Sort By:
Journal of the International AIDS Society|July 27, 2019
Hepatitis C virus elimination: time for disruptive innovationMarina B Klein
The Lancet. HIV|March 23, 2023
Living longer with HIV: gains for some but not for allMarina B Klein
The Lancet. Gastroenterology & Hepatology|January 13, 2022
Simplifying HCV treatment: a pathway to elimination and model for delivering health care to vulnerable populationsMarina B Klein
Expert Review of Anti-Infective Therapy|October 16, 2004
Prevention of HIV-associated opportunistic infections and diseases in the age of highly active antiretroviral therapyPatrick Willemot, Marina B Klein
Current Opinion in HIV and AIDS|August 7, 2015
Epidemiology of hepatitis C virus in HIV-infected patientsLars Peters, Marina B Klein
The Lancet. HIV|June 6, 2022
Can integrase inhibitors reduce mortality?Marina B Klein, Jim Young
Journal of the International AIDS Society|April 11, 2018
The Rocky Road to viral hepatitis elimination: assuring access to antiviral therapy for ALL coinfected patients from low- to high-income settingsKarine Lacombe, Marina B Klein
Women'S Health (London, England)|December 24, 2008
Rapid testing at labor and delivery to prevent mother-to-child HIV transmission in developing settings: issues and challengesNitika Pant Pai, Marina B Klein
Expert Review of Anti-Infective Therapy|December 22, 2006
Structured treatment interruptions in chronic HIV management: where next?Nitika Pant Pai, Marina B Klein
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 15, 2010
Noncirrhotic portal hypertension and didanosine: a re-analysisJim Young, Marina B Klein, Bruno Ledergerber
Pageof 25

Showing results (1-10 of 250) with videos related to

Sort By:
Pageof 25
Journal of the International AIDS Society|July 27, 2019
Hepatitis C virus elimination: time for disruptive innovationMarina B Klein
The Lancet. HIV|March 23, 2023
Living longer with HIV: gains for some but not for allMarina B Klein
The Lancet. Gastroenterology & Hepatology|January 13, 2022
Simplifying HCV treatment: a pathway to elimination and model for delivering health care to vulnerable populationsMarina B Klein
Expert Review of Anti-Infective Therapy|October 16, 2004
Prevention of HIV-associated opportunistic infections and diseases in the age of highly active antiretroviral therapyPatrick Willemot, Marina B Klein
Current Opinion in HIV and AIDS|August 7, 2015
Epidemiology of hepatitis C virus in HIV-infected patientsLars Peters, Marina B Klein
The Lancet. HIV|June 6, 2022
Can integrase inhibitors reduce mortality?Marina B Klein, Jim Young
Journal of the International AIDS Society|April 11, 2018
The Rocky Road to viral hepatitis elimination: assuring access to antiviral therapy for ALL coinfected patients from low- to high-income settingsKarine Lacombe, Marina B Klein
Women'S Health (London, England)|December 24, 2008
Rapid testing at labor and delivery to prevent mother-to-child HIV transmission in developing settings: issues and challengesNitika Pant Pai, Marina B Klein
Expert Review of Anti-Infective Therapy|December 22, 2006
Structured treatment interruptions in chronic HIV management: where next?Nitika Pant Pai, Marina B Klein
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 15, 2010
Noncirrhotic portal hypertension and didanosine: a re-analysisJim Young, Marina B Klein, Bruno Ledergerber
Pageof 25